FAGRB Stock Overview
A pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 3/6 |
Past Performance | 5/6 |
Financial Health | 4/6 |
Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Fagron NV Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €18.72 |
52 Week High | €18.72 |
52 Week Low | €17.58 |
Beta | 0.27 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 46.36% |
Recent News & Updates
Recent updates
Shareholder Returns
FAGRB | GB Healthcare | GB Market | |
---|---|---|---|
7D | 0% | 0.08% | 0.8% |
1Y | n/a | -24.8% | 2.7% |
Return vs Industry: Insufficient data to determine how FAGRB performed against the UK Healthcare industry.
Return vs Market: Insufficient data to determine how FAGRB performed against the UK Market.
Price Volatility
FAGRB volatility | |
---|---|
FAGRB Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 4.6% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 10.4% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: FAGRB's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine FAGRB's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1990 | 3,647 | Rafael Padilla | www.fagron.com |
Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding.
Fagron NV Fundamentals Summary
FAGRB fundamental statistics | |
---|---|
Market cap | €1.37b |
Earnings (TTM) | €77.94m |
Revenue (TTM) | €820.76m |
17.6x
P/E Ratio1.7x
P/S RatioIs FAGRB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FAGRB income statement (TTM) | |
---|---|
Revenue | €820.76m |
Cost of Revenue | €458.22m |
Gross Profit | €362.54m |
Other Expenses | €284.61m |
Earnings | €77.94m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.07 |
Gross Margin | 44.17% |
Net Profit Margin | 9.50% |
Debt/Equity Ratio | 69.2% |
How did FAGRB perform over the long term?
See historical performance and comparisonDividends
1.6%
Current Dividend Yield28%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/10/19 04:44 |
End of Day Share Price | 2024/07/22 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Fagron NV is covered by 15 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Robert Jan Vos | ABN AMRO Bank N.V. |
Marc Leemans | Banque Degroof |
Victoria Lambert | Berenberg |